"Palatin concludes Phase II trial of combination therapy for obesity" was originally created and published by Clinical Trials ...

Last Patient / Last Visit Completed Topline Data Readout Expected Later This Quarter CRANBURY, N.J., Feb. 6, 2025 /PRNewswire/ -- Palatin Technologies, Inc.

Obesity programs: <li /> Phase 2 BMT-801 clinical study with MC4R agonist bremelanotide plus GLP-1/GIP dual agonist tirzepatide ...

Using a rodent stress model, researchers at the Laboratory of Thalamus Research, HUN-REN Institute of Experimental Medicine discovered a sustained increase in neural activity that persisted for ...

Using a rodent stress model, researchers at the Laboratory of Thalamus Research, HUN-REN Institute of Experimental Medicine discovered a sustained ...

The study presents compelling evidence that the melanocortin system originating in the arcuate nucleus of the hypothalamus plays a crucial role in puberty onset, representing a significant advance in ...

The researchers have now come a step closer to mapping this island by discovering the shortest-lived superheavy nucleus known so far, which marks the position of the island's shoreline in nuclei ...

A new milestone in nuclear physics has been achieved with the direct observation of three different deformations in the atomic nucleus of lead-190 (190 Pb). These deformations, associated with ...

supervised clustering of neurons was shown to be a useful method for assessing treatment responses among different neuron subtypes in the hypothalamus. In this report, we utilized single-nucleus ...

LHA = Lateral hypothalamic area; MCH = Melanin-concentrating hormone; NPY = Neuropeptide Y; OXM = Oxyntomodulin; POMC = Pro-opiomelanocortin; PYY = Peptide YY; PVN = Paraventricular nucleus ...